Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity.
Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett. 2003 Apr 25; 193(2):161-70.
View in:
PubMed
subject areas
Adenoviridae
Antineoplastic Agents
Benzamides
beta Catenin
Cell Division
Cell Line
Colonic Neoplasms
Culture Media, Conditioned
Cytoskeletal Proteins
Dose-Response Relationship, Drug
Down-Regulation
Enzyme Inhibitors
Genes, Reporter
Genetic Vectors
Humans
Imatinib Mesylate
Piperazines
Protein-Tyrosine Kinases
Proto-Oncogene Proteins
Pyrimidines
Signal Transduction
Time Factors
Trans-Activators
Transcription, Genetic
Transcriptional Activation
Tumor Cells, Cultured
Wnt Proteins
Wnt1 Protein
Zebrafish Proteins
authors with profiles
Hue H. Luu
Rex C. Haydon
Tong-Chuan He